37 /100
MEDIUM RISK
Score updated May 30, 2026

PLYX — Polaryx Therapeutics, Inc. Dilution Risk Tracker

Track PLYX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PLYX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
77
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 7 points (worsening)
🔔 Track PLYX — Get forecast alerts →

💹 Market Data

Market Cap$163.00M
Shares Outstanding49.85M
Float4.98M
Cash$3.08M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

4.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track PLYX for full holder detail →

📉 Short Interest

Short Interest180.1K
Days to Cover1.1
% of Float3.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track PLYX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PLYX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PLYX
📊 PLYX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PLYX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.